Skip to main content
TipRanks
Go Ultimate75% OFF

Abhay Joshi Insider Profile

4 Followers

Abhay Joshi, former COO, President of R&D at Revance Therapeutics, holds 120.71K shares in Revance Therapeutics (Ticker: RVNC).

Abhay Joshi's Trading History

RVNC
Revance Therapeutics
Mar 17, 2022―Uninformative Sell41.16K$440.58K
RVNC

Abhay Joshi has not reported any informative transactions for RVNC, therefore, performance cannot be measured.

DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Mar 17, 2022Uninformative Sell$41.16K2,607$15.79―
Feb 17, 2022Uninformative Sell$67.46K5,053$13.35―
Mar 17, 2021Uninformative Sell$37.55K1,354$27.73―
Feb 04, 2021Uninformative Buy$0.0022,620$0.00―
Oct 02, 2020Uninformative Sell$185.58K7,382$25.14―

You May Also Like

Abhay Joshi insider profile FAQ

What stocks does Abhay Joshi hold?
Abhay Joshi holds: RVNC stocks.
What was Abhay Joshi’s latest transaction?
Abhay Joshi’s latest transaction was an Uninformative Sell of $41.16K.
What is Abhay Joshi's role in Revance Therapeutics?
Abhay Joshi's role in Revance Therapeutics is COO, President of R&D.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.